98 mn Indians will have diabetes by 2030: Lancet

Monday, 03 December 2018, 05:49 Hrs
30
cmt right
35
Comment Right
49
cmt right
12
cmt right
Printer Print Email Email


While Type-2 diabetes is expected to rise by more than a fifth, from 406 million in 2018 to 511 million in 2030 globally, India along with China and the US will share over half of these high blood sugar cases, say researchers led by one of an Indian-origin, while asserting the need to improve access for the life saving insulin.

The study, published in The Lancet Diabetes and Endocrinology journal, showed that China (130 million) followed by India (98 million), and the US (32 million) will constitute over half of Type-2 diabetics by 2030.

As a result, the amount of insulin needed to effectively treat Type-2 diabetes will rise by more than 20 per cent worldwide over the next 12 years.

Compared to current levels of insulin access, if universal global access was achieved (with a treatment target of HbA1c -- measure of blood glucose) seven per cent or lower, the number of people with Type-2 diabetes worldwide using insulin in 2030 would double from around 38 million (7.4 per cent of all people with Type-2 diabetes) to 79 million (15.5 per cent), the researchers said. 

"Despite the UN's commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily difficult for patients to access," said lead author Sanjay Basu from Stanford University, US.

"The number of adults with Type-2 diabetes is expected to rise over the next 12 years due to ageing, urbanisation, and associated changes in diet and physical activity. 

"Unless governments begin initiatives to make insulin available and affordable, then its use is always going to be far from optimal," Basu said. 

For the study, the team used data from the International Diabetes Federation and 14 cohort studies and estimated the burden of Type-2 diabetes in 221 countries and territories between 2018 and 2030. 

Insulin is essential for all people with Type-1 diabetes and some people with Type-2 diabetes to reduce the risk of complications such as blindness, amputation, kidney failure, and stroke. 

As global rates of Type-2 diabetes soar and people live longer (which will increase insulin requirements), a comprehensive picture of global insulin need is required because insulin treatment is costly and the international insulin market is presently dominated by only three major manufacturers, the researchers noted.



Read more news:



How Much Does the Average US consumer Owe?



Is a Debt Consolidation loan good or bad? Learn About its Advantages and Disadvantages


Source: IANS
SPOTLIGHT
Enterprise IT
Taking on streaming giants like Netflix and Hulu, Walt Disney Co. has announced it will laun..
Business
The Pentagon has selected Microsoft and Amazon Web Services (AWS, the cloud computing arm ..
Career
Wiley, a global leader in research and education has announced a series of blended learning progr..
US Indian
Facebook-owned photo messaging app Instagram has launched the beta version of its in-app sh..
Technology
Facebook-owned messaging app WhatsApp is still developing its previously announced "Vacatio..
Gadgets
Google Pixel and OnePlus smartphones are catching up and giving stiff competition to Samsu..
Entertainment
"Game of Thrones" author George R.R. Martin doesn't want season eight to be the final chapter of "..
Finance
The Reserve Bank of India injected a total liquidity of Rs 2.98 lakh crore in the market in 20..
Startup City
Youth are leading India's start-up ecosystem where the median age of founder-entrepreneurs..